SETD6
N-lysine methyltransferase SETD6
Also known as: FLJ21148, SETD6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TBK2
- Gene
- SETD6
- Ensembl
- ENSG00000103037
- Chromosome
- 16
- Canonical length
- 473 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
This gene encodes a methyltransferase that adds a methyl group to the histone H2AZ, which is involved in nuclear receptor-dependent transcription. The protein also interacts with several endogenous proteins which are involved in nuclear hormone receptor signaling. A related pseudogene is located on chromosome 2. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
473 residues, UniProt reviewed canonical sequence.
>Q8TBK2|SETD6
1 MATQAKRPRV AGPVDGGDLD PVACFLSWCR RVGLELSPKV SERAGGRRTR GGARAALTSP
61 PAQVAVSRQG TVAGYGMVAR ESVQAGELLF VVPRAALLSQ HTCSIGGLLE RERVALQSQS
121 GWVPLLLALL HELQAPASRW RPYFALWPEL GRLEHPMFWP EEERRCLLQG TGVPEAVEKD
181 LANIRSEYQS IVLPFMEAHP DLFSLRVRSL ELYHQLVALV MAYSFQEPLE EEEDEKEPNS
241 PVMVPAADIL NHLANHNANL EYSANCLRMV ATQPIPKGHE IFNTYGQMAN WQLIHMYGFV
301 EPYPDNTDDT ADIQMVTVRE AALQGTKTEA ERHLVYERWD FLCKLEMVGE EGAFVIGREE
361 VLTEEELTTT LKVLCMPAEE FRELKDQDGG GDDKREEGSL TITNIPKLKA SWRQLLQNSV
421 LLTLQTYATD LKTDQGLLSN KEVYAKLSWR EQQALQVRYG QKMILHQLLE LTSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SETD6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 21 nTPM
- pancreas: 16 nTPM
- liver: 12 nTPM
- skin: 12 nTPM
- esophagus: 12 nTPM
- skeletal muscle: 12 nTPM
Single-cell type
- cardiomyocytes: 53 nCPM
- adrenal medulla cells: 53 nCPM
- epicardial cells: 52 nCPM
- adrenal cortex cells: 39 nCPM
- epididymal principal cells: 39 nCPM
- epididymal basal cells: 37 nCPM
Immune cell
- NK-cell: 4.5 nTPM
- basophil: 2.5 nTPM
- naive CD8 T-cell: 2.3 nTPM
- memory CD8 T-cell: 2.2 nTPM
- gdT-cell: 2.1 nTPM
- naive CD4 T-cell: 2 nTPM
Brain region
- cerebellum: 17 nTPM
- cerebral cortex: 6.8 nTPM
- choroid plexus: 6.4 nTPM
- hippocampal formation: 6.4 nTPM
- pons: 6.4 nTPM
- hypothalamus: 6.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.39
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of NF-kappaB transcription factor activity
- peptidyl-lysine monomethylation
- regulation of inflammatory response
- stem cell differentiation
- stem cell population maintenance
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SET domain
- Rubisco LSMT, substrate-binding domain
- Rubisco LSMT, substrate-binding domain superfamily
- SET domain superfamily
- SETD3/SETD6 methyltransferase
- SET domain
- Rubisco LSMT substrate-binding
- N-lysine methyltransferase SETD6
- SETD6, SET domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SETD6 as an antibody target. Whether an autoantibody or antibody against SETD6 could matter depends on whether native SETD6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SETD6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SETD6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...